US Study: Inadequate Nicotine Pouch Packaging Sparks Concerns Over Child Safety

Jul.16.2025
US Study: Inadequate Nicotine Pouch Packaging Sparks Concerns Over Child Safety
A new study shows a 760% surge in nicotine poisoning cases among children under six, with novel nicotine pouches identified as the main culprit. Experts are calling for stronger child safety protections.

Key Points:

 

·From 2020 to 2023, cases of nicotine poisoning in children under 6 increased by 760%. 

 

·The new type of nicotine pouch has been shown to increase the likelihood of serious medical consequences by five times. 

 

·Although the FDA has approved certain nicotine pouches for sale as "reduced harm products," criticism continues.

 

·Experts are calling for restrictions on nicotine pouch flavors and for strengthening child safety measures.

 


 

【2Firsts News Flash】According to a report from Newstarget on July 15th, a new study has shown that cases of poisoning among children under the age of 6 due to ingestion of nicotine pouches increased by a staggering 760% between 2020 and 2023. These non-tobacco nicotine products, some of which have been FDA approved, are five times more likely to result in serious medical consequences compared to other nicotine products.

 

These nicotine pouches often come with enticing sweet flavors and unique designs, dissolving in between the lips and gums. Brands like ZYN, Velo, and Rush are popular among adults as they offer a smoke-free nicotine alternative. However, their appealing flavors and discreet packaging make them resemble candy to children. Studies have shown that although nicotine pouches account for only 1.4% of all nicotine intake, their association with severe consequences, including hospitalization and death, is disproportionate.

 

Dr. Hannah Hays, the medical director of the Central Ohio Poison Center and author of the study, has warned that nicotine pouches pose a serious and growing risk of poisoning in young children. The study analyzed over 134,000 cases of nicotine ingestion reported to poison control centers in the United States from 2010 to 2023. While overall nicotine poisoning has decreased since 2016, incidents related to nicotine pouches have significantly increased.

 

In January 2025, the FDA approved the production of ZYN nicotine pouches by Philip Morris International (PMI), which come in 10 flavors such as coffee, mint, and menthol, marketed as "reduced harm products" for adult smokers. However, anti-tobacco advocates criticized this decision, condemning the FDA for paving the way for a new generation of nicotine addiction. Yolonda Richardson, Chair of Tobacco-Free Kids, stated that...

 

"The FDA should not approve any flavored tobacco products because the tobacco industry has long used flavored products to make people addicted."

 

Although the FDA points out that the percentage of teenagers using nicotine pouches remains low (1.8% of middle and high school students), the sharp increase in child poisonings suggests that current safety measures are inadequate.

 

Nicotine pouches containing 3 to 12 milligrams of concentrated nicotine each far exceed the nicotine content in each cigarette. For children, ingesting even 1 to 2 milligrams may lead to vomiting, seizures, or fatal respiratory failure. Research has found that ingestion of 1.2% of a nicotine pouch can have serious consequences, including two instances of death. In comparison, other nicotine products such as gum or e-liquid have a lower potential for causing severe harm.

 

Philip Morris International (PMI) emphasizes that its packaging already includes child-resistant features and warning labels, but critics argue that these measures are not enough to prevent the rise of poisoning incidents. Dr. Gary Smith from the Nationwide Children's Hospital is calling for stronger regulations, including banning flavored nicotine products and improving child-resistant packaging.

 

The authors of the study emphasize that while legislation such as the 2015 Child Nicotine Poisoning Prevention Act has reduced e-liquid poisoning, urgent intervention is needed to address the crisis of nicotine pouches.

 

"Banning flavors in all nicotine products helps reduce accidental ingestion by young children and discourages use by teenagers."

 

Smith pointed out.

 

While the tobacco industry profits from FDA-approved nicotine replacement products, two recent fatal incidents serve as a reminder that children's safety should not be compromised for corporate gains. Until stricter regulations are in place, parents remain the last line of defense in preventing this preventable epidemic.

 


Cover image credit: Newstarget

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Mesa Underwriters Specialty Insurance Company has asked a federal court in Washington to declare that it has no duty to defend or indemnify vape distributor i5 Distribution in a product liability case involving an Elf Bar BC5000. The plaintiff alleges that the disposable vape caught fire and exploded in his pocket, causing severe burns and ultimately requiring an above-the-knee amputation of his left leg. MUSIC is relying on a tobacco, nicotine or nicotine replacement products exclusion and a premises limitation endorsement. The court has not ruled on the coverage dispute.
News
Sep.10
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
A U.S. Customs and Border Protection proposal to collect foreign export declarations and other overseas customs documents could expose discrepancies in the value, classification and description of China-made vape shipments entering the United States. A veteran Chinese logistics professional told 2Firsts that the measure, if implemented, could undermine the all-inclusive shipping model used by some unauthorized vape exporters and push parts of the trade toward costlier underground channels. The risk extends beyond higher duties: accurately declared products may also be more readily identified as unauthorized e-cigarettes subject to FDA enforcement.
Special Report
Sep.07
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15